Valuation: Certara, Inc.

Market Cap 1.28B 1.11B 1.05B 953M 1.79B 123B 1.8B 12.53B 4.84B 62.35B 4.81B 4.71B 199B P/E 2026 *
-40.7x
P/E 2027 * 896x
Enterprise Value 1.34B 1.16B 1.1B 994M 1.86B 128B 1.87B 13.07B 5.05B 65.06B 5.02B 4.91B 207B EV / Sales 2026 *
3.52x
EV / Sales 2027 * 3.23x
Free-Float
67.08%
Yield 2026 *
-
Yield 2027 * -
1 day-3.21%
1 week+6.55%
Current month-1.93%
1 month+1.62%
3 months+34.38%
6 months+25.27%
Current year-7.72%
1 week 7.31
Extreme 7.31
8.4
1 month 7.31
Extreme 7.31
8.88
Current year 4.45
Extreme 4.45
10.2
1 year 4.45
Extreme 4.45
13.88
3 years 4.45
Extreme 4.45
19.87
5 years 4.45
Extreme 4.45
45.48
10 years 4.45
Extreme 4.45
45.48
Manager TitleAgeSince
Chief Executive Officer 53 01/01/2026
Director of Finance/CFO 53 15/07/2026
Chief Tech/Sci/R&D Officer - 31/07/2025
Director TitleAgeSince
Chairman 72 01/12/2021
Director/Board Member 68 01/01/2013
Director/Board Member 59 01/08/2017
Date Insider Type Main position Quantity % Market Cap. Importance
01/09/26 Free

Chief Financial Officer

63,532 0.0416%
15/07/26 Other

Chief Financial Officer

191,850 0.1233%
01/06/26 Exercice

General Counsel

57,763 0.0371%
Change 5-day change 1-year change 3-year change Capi.($)
-3.21%+6.55%-29.61%-41.85% 1.28B
-1.37%-0.27%-3.68%+49.00% 3,691B
+1.03%+2.84%+2.40%+1,027.68% 415B
+0.23%+2.45%+71.48%+144.22% 82.68B
+2.17%-1.65%-19.80%+18.19% 75.45B
+2.93%-3.75%-11.15%-17.73% 70.46B
+0.83%-4.79%-45.26%+170.38% 62.87B
+0.25%+7.06%+10.60%-7.13% 48.05B
-0.05%+0.32%-14.50%+49.87% 39.62B
-5.59%+6.54%-65.08%+71.79% 35.89B
Average -0.16%+1.31%-10.46%+146.44% 452.24B
Weighted average by Cap. -0.96%+1.14%-3.15%+140.18%

Financials

2026 *2027 *
Net sales 380M 329M 311M 283M 530M 36.46B 533M 3.72B 1.44B 18.49B 1.43B 1.4B 58.95B 390M 338M 319M 290M 543M 37.37B 546M 3.81B 1.47B 18.95B 1.46B 1.43B 60.42B
Net income -28.37M -24.59M -23.24M -21.1M -39.54M -2.72B -39.77M -277M -107M -1.38B -107M -104M -4.4B 1.74M 1.51M 1.42M 1.29M 2.42M 167M 2.44M 16.99M 6.56M 84.54M 6.53M 6.38M 269M
Net Debt 55.8M 48.36M 45.71M 41.5M 77.77M 5.35B 78.24M 546M 211M 2.72B 210M 205M 8.65B -23.11M -20.03M -18.93M -17.19M -32.21M -2.22B -32.41M -226M -87.33M -1.12B -86.83M -84.9M -3.58B
Logo Certara, Inc.
Certara, Inc. is a provider of biosimulation science, technology, and consulting services for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical and biotech industry. The Company's proprietary biosimulation platforms are built on biology, chemistry, and pharmacology principles with proprietary mathematical algorithms that model how medicines and diseases behave in the body. It has developed scientifically-based solutions for the collection, standardization, validation, storage, and analysis of the preclinical, clinical and evidence data needed for MIDD. These data solutions are used internally and industry-wide by life sciences companies. The Company applies AI capabilities within established modeling environments and under the supervision of experienced scientists and regulatory experts. Its modeling platforms and curated datasets position it to incorporate emerging AI techniques in a controlled and scientifically rigorous manner.
Employees
1,546
Date Price Change Volume
17/09/26 $8.130 -3.21% 3,519,277
15/09/26 $8.400 +5.00% 2,121,495
14/09/26 $8.000 +5.96% 1,695,952
11/09/26 $7.550 +1.75% 1,487,180
10/09/26 $7.420 -2.75% 2,255,175
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
8.400USD
Average target price
8.335USD
Spread / Average Target
-0.77%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CERT Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!